| 中文名 | 1-[3-叠氮基-2,3-二脱氧-5-O-(三苯基甲基)-BETA-D-苏式-呋喃戊糖基]-5-甲基-2,4(1H,3H)-嘧啶二酮 |
|---|---|
| 英文名 | 1-[3'-azido-2',3'-dideoxy-5'-(triphenylmethyl)-β-D-threo-pentofuranosyl]-5-methylpyrimidine-2,4(1H,3H)-dione |
| 英文别名 |
1-(3'-azido-2',3'-dideoxy-5'-O-trityl-β-D-xylofuranosyl)thymine
3’-β-Azido-3’-deoxy-5’-O-trityl thymidine 1-(3-azido-O5-trityl-β-D-threo-2,3-dideoxy-pentofuranosyl)-5-methyl-1H-pyrimidine-2,4-dione 3'-beta-Azido-3'-deoxy-5'-O-trityl thyMidine 1-(3-Azido-2,3-dideoxy-5-O-trityl-β-D-threo-pentofuranosyl)thymine 1-(3-b-Azido-2,3-dideoxy-5-O-trityl-b-D-threopenta furanosyl) thymine 1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine 1-[3-Azido-2,3-dideoxy-5-O-(triphenylmethyl)-beta-D-threo-pentofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione |
| 描述 | 1-(3-β-叠氮-2,3-二脱氧-5-O-三丁基-D-呋喃基)胸腺嘧啶是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C29H27N5O4 |
|---|---|
| 分子量 | 509.56 |
| 精确质量 | 509.20600 |
| PSA | 123.07000 |
| LogP | 4.27286 |
| 上游产品 0 | |
|---|---|
| 下游产品 1 | |